Barends Hieke, van der Horst Henriëtte E, van der Wouden Johannes C, Claassen Nikki, Dekker Joost, Hoekstra Trynke
Department of General Practice, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands
Amsterdam Public Health research institute, Amsterdam, The Netherlands.
BMJ Open. 2025 Jan 8;15(1):e083276. doi: 10.1136/bmjopen-2023-083276.
Knowledge about the long-term course and prognosis of persistent somatic symptoms (PSS) is important to improve clinical decision-making and guidance for patients with PSS. Therefore, we aimed to: (1) identify distinct 5-year trajectories of symptom severity, physical and mental functioning in adult patients with PSS and (2) explore patient characteristics associated with these trajectories.
We used longitudinal data (seven measurements over a 5-year period) of the PROSPECTS study: a prospective cohort of adult patients with PSS. We applied Latent Class Growth Mixture Modelling to identify distinct trajectories for the three outcomes.
Patients were recruited in general practices and specialised treatment facilities for PSS throughout the Netherlands. The study population consisted of participants with three or more measurements available (n=297).
Symptom severity (Patient Health Questionnaire 15), physical and mental functioning (RAND-36 Physical Component Summary and Mental Component Summary).
For symptom severity, we identified two 'stable' trajectories: 'severe symptoms, stable' (15.8%) and 'moderate symptoms, stable' (84.2%). For physical functioning, we identified three trajectories: 'poor physical functioning, marked improvement' (8.5%); 'poor physical functioning, stable' (34.7%) and 'moderate physical functioning, slight improvement' (56.8%). For mental functioning, we identified three trajectories: 'poor mental functioning, marked improvement' (13.9%); 'moderate mental functioning, deterioration' (12.2%) and 'moderate mental functioning, slight improvement' (73.8%). Patients' characteristics such as personal, social and environmental background, illness stressors, comorbid diseases, cognitive, emotional and behavioural responses varied for the distinct trajectories.
We identified distinct 5-year trajectories for the three outcomes. Our findings suggest a high prevalence of persistence of symptoms and limited improvement in physical and mental functioning in the majority of patients with PSS. In a small proportion of patients, we identified trajectories that showed considerable physical or mental improvement or deterioration. Patient characteristics differed for the identified trajectories and may guide early recognition, although predictive studies are warranted.
了解持续性躯体症状(PSS)的长期病程和预后对于改善临床决策以及为PSS患者提供指导至关重要。因此,我们旨在:(1)确定成年PSS患者症状严重程度、身体和心理功能的5年不同轨迹,以及(2)探索与这些轨迹相关的患者特征。
我们使用了PROSPECTS研究的纵向数据(5年期间进行了7次测量):一项成年PSS患者的前瞻性队列研究。我们应用潜在类别增长混合模型来确定这三个结果的不同轨迹。
患者在荷兰各地的全科诊所和PSS专门治疗机构招募。研究人群包括有三次或更多次可用测量数据的参与者(n = 297)。
症状严重程度(患者健康问卷15)、身体和心理功能(兰德36项健康调查简表身体成分总结和心理成分总结)。
对于症状严重程度,我们确定了两条“稳定”轨迹:“严重症状,稳定”(15.8%)和“中度症状,稳定”(84.2%)。对于身体功能,我们确定了三条轨迹:“身体功能差,显著改善”(8.5%);“身体功能差,稳定”(34.7%)和“中度身体功能,略有改善”(56.8%)。对于心理功能,我们确定了三条轨迹:“心理功能差,显著改善”(13.9%);“中度心理功能,恶化”(12.2%)和“中度心理功能,略有改善”(73.8%)。不同轨迹的患者特征,如个人、社会和环境背景、疾病应激源、合并疾病、认知、情绪和行为反应各不相同。
我们确定了这三个结果的5年不同轨迹。我们的研究结果表明,大多数PSS患者症状持续存在的患病率很高,身体和心理功能改善有限。在一小部分患者中,我们确定了显示身体或心理有显著改善或恶化的轨迹。已确定轨迹的患者特征不同,可能有助于早期识别,尽管仍需进行预测性研究。